6353087
Last Update Posted: 2025-05-13
Recruiting
All Genders accepted | 12 Years + |
200 Estimated Participants | No Expanded Access |
Observational Study | Does not accept healthy volunteers |
Abrocitinib Taiwan Treatment Pattern and Real World Study in ATopiC Dermatitis (ATTRACT Registry)
This study is to describe the real-world treatment patterns and clinical outcomes in moderate-to-severe AD patients receiving abrocitinib over a 12-month observation period, and to describe patient demographic and baseline characteristics.
Eligibility
Relevant conditions:
Dermatitis, Atopic
Dermatitis
Eczema
Skin Diseases
Immune System Diseases
Janus Kinase Inhibitors
If you aren't sure if you meet the criteria above speak to your healthcare professional. Criteria may be updated but not reflected here, do not hesitate to contact the trial if you think are close to fitting criteria.
locations
Contact Information
Overall Contact
Data sourced from ClinicalTrials.gov